Related Experiment Videos
Erythroderma: review of 82 cases
Southern Medical Journal
|October 1, 1986
Summary
Erythroderma is often caused by drug eruptions, existing skin conditions, or lymphomas like CTCL. Prognosis depends on the cause, with deaths linked to drug reactions or lymphoma. Early diagnosis and monitoring are crucial.
Area of Science:
- Dermatology
- Oncology
- Pathology
Background:
- Erythroderma is a severe skin condition affecting over 10% of the body surface.
- Identifying the underlying cause of erythroderma is crucial for prognosis and treatment.
Purpose of the Study:
- To analyze the causes, clinical presentation, and outcomes of erythroderma.
- To evaluate the diagnostic utility of various investigations in erythroderma.
Main Methods:
- Retrospective review of 82 erythroderma cases.
- Analysis of clinical, laboratory, and biopsy data.
- Correlation of erythroderma causes with patient prognosis.
Main Results:
- Common causes include drug eruptions (34%), preexisting dermatoses (30%), and lymphoreticular neoplasms (20%), particularly cutaneous T cell lymphomas (CTCL).
- Malaise, pruritus, and subjective chilly sensations were frequent symptoms. Keratoderma and mild adenopathy were common physical findings.
- Skin biopsy was diagnostic in 43% of cases; Sezary cell preparation was specific for CTCL. All deaths occurred in drug eruption or lymphoma groups.
Conclusions:
- Erythroderma etiology varies, with drug reactions, dermatoses, and CTCL being most frequent.
- Chronic erythroderma without a clear cause may indicate underlying CTCL, necessitating close follow-up.
- Prognosis is tied to the underlying condition, highlighting the importance of accurate diagnosis.